TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $430,390 | +41.1% | 27,821 | +43.3% | 0.04% | +52.0% |
| Q2 2023 | $305,010 | -12.9% | 19,415 | -8.6% | 0.02% | -21.9% |
| Q1 2023 | $350,168 | +73.4% | 21,248 | +64.2% | 0.03% | +60.0% |
| Q4 2022 | $201,925 | -37.7% | 12,944 | -48.2% | 0.02% | -41.2% |
| Q3 2022 | $324,000 | +105.1% | 24,985 | +120.8% | 0.03% | +112.5% |
| Q2 2022 | $158,000 | -46.1% | 11,314 | -44.6% | 0.02% | -38.5% |
| Q1 2022 | $293,000 | +23.6% | 20,424 | +17.8% | 0.03% | +30.0% |
| Q4 2021 | $237,000 | -16.8% | 17,338 | -0.4% | 0.02% | -23.1% |
| Q3 2021 | $285,000 | +7.5% | 17,400 | +10.6% | 0.03% | +4.0% |
| Q2 2021 | $265,000 | -15.1% | 15,730 | -7.9% | 0.02% | -19.4% |
| Q1 2021 | $312,000 | +16.4% | 17,073 | +15.9% | 0.03% | 0.0% |
| Q4 2020 | $268,000 | -8.8% | 14,732 | -10.5% | 0.03% | -20.5% |
| Q3 2020 | $294,000 | +12.2% | 16,452 | +12.6% | 0.04% | +5.4% |
| Q2 2020 | $262,000 | – | 14,610 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |